# A Study of Capravirine Plus VIRACEPT Plus Two Nucleoside Reverse Transcriptase Inhibitors in HIV-Infected Patients Who Failed Previous Anti-HIV Treatments

> **NCT00006211** · PHASE2 · COMPLETED · sponsor: **Agouron Pharmaceuticals** · enrollment: 350 (—)

## Conditions studied

- HIV Infections

## Interventions

- **DRUG:** Capravirine
- **DRUG:** Nelfinavir mesylate

## Key facts

- **NCT ID:** NCT00006211
- **Lead sponsor:** Agouron Pharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2000-02
- **Primary completion:** —
- **Final completion:** 2001-04
- **Target enrollment:** 350 (—)
- **Last updated:** 2005-06-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00006211

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00006211, "A Study of Capravirine Plus VIRACEPT Plus Two Nucleoside Reverse Transcriptase Inhibitors in HIV-Infected Patients Who Failed Previous Anti-HIV Treatments". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00006211. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*